Rotten Tomato Stocks
No Result
View All Result
  • News
    Stocks Drop in an Ugly Day as Allure Grows to Buy a Treasury Bill and Chill

    Stocks Drop in an Ugly Day as Allure Grows to Buy a Treasury Bill and Chill

    15,000 Pounds Of Smoked Sausage Recalled For ‘Bone Fragments’ After Being Shipped To Seven States

    15,000 Pounds Of Smoked Sausage Recalled For ‘Bone Fragments’ After Being Shipped To Seven States

    Asian Shares Decline Ahead of Fed Decision on Rates

    Asian Shares Decline Ahead of Fed Decision on Rates

    Canadian Food Inspection Agency orders mushroom recall for Listeria contamination

    Canadian Food Inspection Agency orders mushroom recall for Listeria contamination

  • NYSE
    Greenfire Resources Shares Fall on NYSE Debut

    Greenfire Resources Shares Fall on NYSE Debut

    Salesforce Inc. stock falls Thursday, underperforms market

    Salesforce Inc. stock falls Thursday, underperforms market

    These 4 Measures Indicate That Sempra (NYSE:SRE) Is Using Debt Extensively

    These 4 Measures Indicate That Sempra (NYSE:SRE) Is Using Debt Extensively

    Oracle (NYSE:ORCL) Takes On Some Risk With Its Use Of Debt

    Oracle (NYSE:ORCL) Takes On Some Risk With Its Use Of Debt

  • NASDAQ
    Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 5.1% in August

    Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 5.1% in August

    Beyond Meat Inc. stock falls Thursday, underperforms market

    Beyond Meat Inc. stock falls Thursday, underperforms market

    Brighthouse Financial Shares Fall 6.7% on Goldman Sachs Rating Cut

    Brighthouse Financial Shares Fall 6.7% on Goldman Sachs Rating Cut

    Real Good Food Revenue Falls on Tough Market Conditions in US, Europe

    Real Good Food Revenue Falls on Tough Market Conditions in US, Europe

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

  • News
    Stocks Drop in an Ugly Day as Allure Grows to Buy a Treasury Bill and Chill

    Stocks Drop in an Ugly Day as Allure Grows to Buy a Treasury Bill and Chill

    15,000 Pounds Of Smoked Sausage Recalled For ‘Bone Fragments’ After Being Shipped To Seven States

    15,000 Pounds Of Smoked Sausage Recalled For ‘Bone Fragments’ After Being Shipped To Seven States

    Asian Shares Decline Ahead of Fed Decision on Rates

    Asian Shares Decline Ahead of Fed Decision on Rates

    Canadian Food Inspection Agency orders mushroom recall for Listeria contamination

    Canadian Food Inspection Agency orders mushroom recall for Listeria contamination

  • NYSE
    Greenfire Resources Shares Fall on NYSE Debut

    Greenfire Resources Shares Fall on NYSE Debut

    Salesforce Inc. stock falls Thursday, underperforms market

    Salesforce Inc. stock falls Thursday, underperforms market

    These 4 Measures Indicate That Sempra (NYSE:SRE) Is Using Debt Extensively

    These 4 Measures Indicate That Sempra (NYSE:SRE) Is Using Debt Extensively

    Oracle (NYSE:ORCL) Takes On Some Risk With Its Use Of Debt

    Oracle (NYSE:ORCL) Takes On Some Risk With Its Use Of Debt

  • NASDAQ
    Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 5.1% in August

    Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 5.1% in August

    Beyond Meat Inc. stock falls Thursday, underperforms market

    Beyond Meat Inc. stock falls Thursday, underperforms market

    Brighthouse Financial Shares Fall 6.7% on Goldman Sachs Rating Cut

    Brighthouse Financial Shares Fall 6.7% on Goldman Sachs Rating Cut

    Real Good Food Revenue Falls on Tough Market Conditions in US, Europe

    Real Good Food Revenue Falls on Tough Market Conditions in US, Europe

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

No Result
View All Result
Rotten Tomato Stocks
No Result
View All Result

Is Seres Therapeutics (NASDAQ:MCRB) Weighed On By Its Debt Load?

Editorial Staff by Editorial Staff
September 3, 2021
0
Is Seres Therapeutics (NASDAQ:MCRB) Weighed On By Its Debt Load?

Seres Therapeutics seen in Cambridge, Massachusetts, on Oct. 5, 2018. (Ruby Wallau for STAT)

David Iben put it well when he said, ‘Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.’ It’s only natural to consider a company’s balance sheet when you examine how risky it is, since debt is often involved when a business collapses. As with many other companies Seres Therapeutics, Inc. (NASDAQ:MCRB) makes use of debt. But should shareholders be worried about its use of debt?

When Is Debt Dangerous?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. If things get really bad, the lenders can take control of the business. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, plenty of companies use debt to fund growth, without any negative consequences. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

What Is Seres Therapeutics’s Net Debt?

The chart below, which you can click on for greater detail, shows that Seres Therapeutics had US$25.3m in debt in June 2021; about the same as the year before. However, its balance sheet shows it holds US$214.6m in cash, so it actually has US$189.2m net cash.

debt-equity-history-analysis
NasdaqGS:MCRB Debt to Equity History September 3rd 2021

A Look At Seres Therapeutics’ Liabilities

Zooming in on the latest balance sheet data, we can see that Seres Therapeutics had liabilities of US$56.2m due within 12 months and liabilities of US$112.4m due beyond that. Offsetting this, it had US$214.6m in cash and US$1.25m in receivables that were due within 12 months. So it actually has US$47.2m more liquid assets than total liabilities.

This surplus suggests that Seres Therapeutics has a conservative balance sheet, and could probably eliminate its debt without much difficulty. Succinctly put, Seres Therapeutics boasts net cash, so it’s fair to say it does not have a heavy debt load! The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately the future profitability of the business will decide if Seres Therapeutics can strengthen its balance sheet over time.

Over 12 months, Seres Therapeutics reported revenue of US$30m, which is a gain of 3.7%, although it did not report any earnings before interest and tax. We usually like to see faster growth from unprofitable companies, but each to their own.

So How Risky Is Seres Therapeutics?

By their very nature companies that are losing money are more risky than those with a long history of profitability. And the fact is that over the last twelve months Seres Therapeutics lost money at the earnings before interest and tax (EBIT) line. And over the same period it saw negative free cash outflow of US$117m and booked a US$132m accounting loss. But at least it has US$189.2m on the balance sheet to spend on growth, near-term. Even though its balance sheet seems sufficiently liquid, debt always makes us a little nervous if a company doesn’t produce free cash flow regularly. 

Related Posts

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 5.1% in August
NASDAQ

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 5.1% in August

September 21, 2023
Beyond Meat Inc. stock falls Thursday, underperforms market
NASDAQ

Beyond Meat Inc. stock falls Thursday, underperforms market

September 21, 2023
Brighthouse Financial Shares Fall 6.7% on Goldman Sachs Rating Cut
NASDAQ

Brighthouse Financial Shares Fall 6.7% on Goldman Sachs Rating Cut

September 21, 2023
Real Good Food Revenue Falls on Tough Market Conditions in US, Europe
NASDAQ

Real Good Food Revenue Falls on Tough Market Conditions in US, Europe

September 21, 2023
Load More
Next Post
We Think Cyren (NASDAQ:CYRN) Has A Fair Chunk Of Debt

We Think Cyren (NASDAQ:CYRN) Has A Fair Chunk Of Debt

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

POPULAR NEWS

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

April 14, 2021
CN Rail Stock Is So Undervalued That it’s Absurd

CN Rail Stock Is So Undervalued That it’s Absurd

May 2, 2021
Corus Entertainment 4Q Profit Falls

Corus Entertainment 4Q Profit Falls

October 22, 2021
Bitcoin Is Falling: Should You Buy the Dip?

Bitcoin Is Falling: Should You Buy the Dip?

May 3, 2021
US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

June 17, 2021

EDITOR'S PICK

Is McGrath RentCorp (NASDAQ:MGRC) Using Too Much Debt?

Is McGrath RentCorp (NASDAQ:MGRC) Using Too Much Debt?

May 7, 2023
Freshworks (NASDAQ:FRSH) Shares Down 7.5% After Analyst Downgrade

Freshworks (NASDAQ:FRSH) Shares Down 7.5% After Analyst Downgrade

July 28, 2022
Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

March 24, 2023
Cocktail shrimp sold at Lidl stores recalled after testing finds Listeria

Cocktail shrimp sold at Lidl stores recalled after testing finds Listeria

March 5, 2023

Stay Updated

Get breaking news delivered straight into your inbox

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Rotten Tomato stocks is a wholly-owned subsidiary of Grainne Capital Limited.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Rotten Tomato Stocks cover the companies and markets that are declining, failing or headed for disaster. We help investors spot the down tends and recognize when something smells rotten.

RECENT POSTS

Stocks Drop in an Ugly Day as Allure Grows to Buy a Treasury Bill and Chill

Greenfire Resources Shares Fall on NYSE Debut

Salesforce Inc. stock falls Thursday, underperforms market

POPULAR POSTS

These 4 Measures Indicate That Sempra (NYSE:SRE) Is Using Debt Extensively

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 5.1% in August

Beyond Meat Inc. stock falls Thursday, underperforms market

© Copyright 2023 RottenTomatoStocks. All Rights Reserved 

Disclaimer | Privacy Policy

No Result
View All Result
  • HOME
  • NEWS
  • NYSE
  • NASDAQ
  • OTC
  • TSX

© 2021 RottenTomatoStocks.com

error: Content is protected !!
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.